DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis
出版年份 2020 全文链接
标题
DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis
作者
关键词
-
出版物
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-01
DOI
10.1007/s00018-020-03626-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins
- (2020) Yuchen Gu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice
- (2019) Benoît Souchet et al. Acta Neuropathologica Communications
- Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence
- (2019) Xiuhua Xu et al. Cell Death & Disease
- CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells
- (2019) Eduardo Silva-Pavez et al. Cell Death & Disease
- An update on the association of protein kinases with cardiovascular diseases
- (2019) Fakhra Amin et al. CURRENT PHARMACEUTICAL DESIGN
- DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169
- (2019) Vijay R. Menon et al. CELL CYCLE
- Vascular defects of DYRK1A knockouts are ameliorated by modulating calcium signaling in zebrafish
- (2019) Hyun-Ju Cho et al. Disease Models & Mechanisms
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- DYRK1A-related intellectual disability: a syndrome associated with congenital anomalies of the kidney and urinary tract
- (2019) Alexandria T. M. Blackburn et al. GENETICS IN MEDICINE
- The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer
- (2019) Débora Kristina Alves-Fernandes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
- (2019) R. Velazquez et al. MOLECULAR NEUROBIOLOGY
- The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair
- (2019) Steven E. Guard et al. Scientific Reports
- A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response
- (2019) Julia Roewenstrunk et al. Scientific Reports
- DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild‐type NSCLC cells to AZD9291
- (2019) Yang‐ling Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade
- (2019) Ching-Chi Chiu et al. Frontiers in Cellular Neuroscience
- Identification of a PEST Sequence in Vertebrate KIR2.1 That Modifies Rectification
- (2019) Muge Qile et al. Frontiers in Physiology
- microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing
- (2019) Juliana C.S. Chaves et al. NEUROSCIENCE LETTERS
- Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma
- (2018) Katie L. Uhl et al. Cancer Cell International
- Homologous recombination and the repair of DNA double-strand breaks
- (2018) William Douglass Wright et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- Targeting GLI Transcription Factors in Cancer
- (2018) Miroslava Didiasova et al. MOLECULES
- Metabolic Kinases Moonlighting as Protein Kinases
- (2018) Zhimin Lu et al. TRENDS IN BIOCHEMICAL SCIENCES
- DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
- (2018) Fernanda Neumann et al. Scientific Reports
- DYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells
- (2018) Esteban J. Rozen et al. Cell Reports
- Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism
- (2018) Esti Wahyu Widowati et al. Biology Open
- miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression
- (2018) Yi Chu et al. FEBS Open Bio
- Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
- (2018) Thu Lan Nguyen et al. Disease Models & Mechanisms
- DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers
- (2018) Shanshan Li et al. NUCLEIC ACIDS RESEARCH
- RNF169 limits 53BP1 deposition at DSBs to stimulate single-strand annealing repair
- (2018) Liwei An et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- MiR-204-5p promotes apoptosis and inhibits migration of osteosarcoma via targeting EBF2
- (2018) Mao Li et al. BIOCHIMIE
- DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
- (2018) Jeroni Luna et al. GUT
- Therapeutic targeting of cellular stress responses in cancer
- (2018) Miao Chen et al. Thoracic Cancer
- The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)
- (2017) Fatima Ardito et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
- (2017) Ursula A. Germann et al. MOLECULAR CANCER THERAPEUTICS
- Non-homologous DNA end joining and alternative pathways to double-strand break repair
- (2017) Howard H. Y. Chang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions
- (2017) Smruthi Vijayaraghavan et al. Targeted Oncology
- The RNF168 paralog RNF169 defines a new class of ubiquitylated histone reader involved in the response to DNA damage
- (2017) Julianne Kitevski-LeBlanc et al. eLife
- Integration of pro- and anti-angiogenic signals by endothelial cells
- (2017) Shideh Kazerounian et al. Journal of Cell Communication and Signaling
- NFATc1 phosphorylation by DYRK1A increases its protein stability
- (2017) Heng Liu et al. PLoS One
- Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice
- (2017) Xiaomin Yin et al. Scientific Reports
- DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain
- (2017) Samira Abu Jhaisha et al. Scientific Reports
- Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling
- (2016) Susanne Hille et al. CARDIOVASCULAR RESEARCH
- A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
- (2016) Hyeongki Kim et al. Disease Models & Mechanisms
- Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells
- (2016) Raafat A. El-Awady et al. DNA REPAIR
- DYRK1A inhibition as potential treatment for Alzheimer’s disease
- (2016) Silvia Stotani et al. Future Medicinal Chemistry
- Dynamin 1- and 3-Mediated Endocytosis Is Essential for the Development of a Large Central Synapse In Vivo
- (2016) Fan Fan et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2016) Rafael de la Torre et al. LANCET NEUROLOGY
- Association of DYRK1A polymorphisms with sporadic Parkinson’s disease in Chinese Han population
- (2016) Luan Cen et al. NEUROSCIENCE LETTERS
- Selective inhibition of the kinase DYRK1A by targeting its folding process
- (2016) Isao Kii et al. Nature Communications
- A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
- (2016) Aneesha Radhakrishnan et al. Scientific Reports
- DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model
- (2015) N. Kurabayashi et al. EMBO REPORTS
- DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies
- (2015) Jianling Ji et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP/PS1 transgenic mice and scopolamine-induced memory impairment mice
- (2015) Dandan He et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I
- (2015) Nana Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chromatin-wide Profiling of DYRK1A Reveals a Role as a Gene-Specific RNA Polymerase II CTD Kinase
- (2015) Chiara Di Vona et al. MOLECULAR CELL
- DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
- (2015) Ramzi Abbassi et al. PHARMACOLOGY & THERAPEUTICS
- Dissecting Alzheimer disease in Down syndrome using mouse models
- (2015) Xun Yu Choong et al. Frontiers in Behavioral Neuroscience
- Targeting RTK Signaling Pathways in Cancer
- (2015) Tarik Regad Cancers
- RE-1 silencing transcription factor (REST): a regulator of neuronal development and neuronal/endocrine function
- (2014) Gerald Thiel et al. CELL AND TISSUE RESEARCH
- The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1and Cyclin D1 and induces cell cycle exit and neuronal differentiation
- (2014) Ulf Soppa et al. CELL CYCLE
- DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression
- (2014) S. M. Jang et al. EMBO REPORTS
- 53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
- (2014) J. M. Daley et al. MOLECULAR AND CELLULAR BIOLOGY
- Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
- (2014) Qiang Liu et al. PLoS One
- DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson’s disease
- (2014) M J Barallobre et al. Cell Death & Disease
- Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy
- (2013) Elena Lecumberri et al. CLINICAL NUTRITION
- Mechanism of dual specificity kinase activity of DYRK1A
- (2013) Agnes Walte et al. FEBS Journal
- Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
- (2013) Natividad Pozo et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity
- (2013) Stéphanie Gourdain et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
- (2013) Rafael De la Torre et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition
- (2013) Meera Soundararajan et al. STRUCTURE
- DNA Damage Sensing by the ATM and ATR Kinases
- (2013) A. Marechal et al. Cold Spring Harbor Perspectives in Biology
- Pulmonary Vein Stenosis with Down Syndrome: A Rare and Frequently Fatal Cause of Pulmonary Hypertension in Infants and Children
- (2013) Srinath Gowda et al. Congenital Heart Disease
- The Protein Interaction Landscape of the Human CMGC Kinase Group
- (2013) Markku Varjosalo et al. Cell Reports
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?
- (2012) Breland Smith et al. ACS Chemical Neuroscience
- Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin
- (2012) Ekram M. Saleh et al. BIOMEDICINE & PHARMACOTHERAPY
- NFATc1/αA: The other Face of NFAT Factors in Lymphocytes
- (2012) Edgar Serfling et al. Cell Communication and Signaling
- Human RNF169 is a negative regulator of the ubiquitin-dependent response to DNA double-strand breaks
- (2012) Maria Poulsen et al. JOURNAL OF CELL BIOLOGY
- Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
- (2012) Sébastien Malinge et al. JOURNAL OF CLINICAL INVESTIGATION
- Dyrk1A, a Serine/Threonine Kinase, is Involved in ERK and Akt Activation in the Brain of Hyperhomocysteinemic Mice
- (2012) Sabiha Abekhoukh et al. MOLECULAR NEUROBIOLOGY
- Therapeutic targets in the ASK1-dependent stress signaling pathways
- (2012) Ryoichi HAYAKAWA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea
- (2012) Guang-Jian Du et al. Nutrients
- Letter concerning: 'Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo'
- (2011) P. A. da Costa Martins et al. CARDIOVASCULAR RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Mammalian Sirt1: insights on its biological functions
- (2011) Shahedur Rahman et al. Cell Communication and Signaling
- Phosphorylation of p53 on Ser15 during cell cycle and caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation
- (2011) Hong Zhao et al. CELL CYCLE
- p53 downregulates Down syndrome-associated DYRK1A through miR-1246
- (2011) Yu Zhang et al. EMBO REPORTS
- DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly
- (2011) L. Litovchick et al. GENES & DEVELOPMENT
- Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death
- (2011) Hyoung Kyoung Choi et al. Experimental Neurobiology
- Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?
- (2010) Raafat A. El-Awady et al. ANTI-CANCER DRUGS
- Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
- (2010) Tatyana Adayev et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
- (2010) Samuel F. Bunting et al. CELL
- DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles
- (2010) Sergi Aranda et al. FASEB JOURNAL
- MNB/DYRK1A as a multiple regulator of neuronal development
- (2010) Francisco J. Tejedor et al. FEBS Journal
- The role of DYRK1A in neurodegenerative diseases
- (2010) Jerzy Wegiel et al. FEBS Journal
- DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1
- (2010) Xiumei Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells
- (2010) Joongkyu Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling
- (2010) Paula A. da Costa Martins et al. NATURE CELL BIOLOGY
- Characterization of a Domain That Transiently Converts Class 2 DYRKs into Intramolecular Tyrosine Kinases
- (2010) R. Kinstrie et al. Science Signaling
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- p38α- and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress
- (2009) Anne Seifert et al. CELLULAR SIGNALLING
- Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project
- (2009) Sallie B Freeman et al. GENETICS IN MEDICINE
- DYRK1A Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy
- (2009) Christian Kuhn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A
- (2009) J. Fernandez-Martinez et al. JOURNAL OF CELL SCIENCE
- Role of Endogenous Angiogenesis Inhibitors in Down Syndrome
- (2009) Sandra Ryeom et al. JOURNAL OF CRANIOFACIAL SURGERY
- Down Syndrome and Malignancies: A Unique Clinical Relationship
- (2009) Ana C. Xavier et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Kinase mutations in human disease: interpreting genotype–phenotype relationships
- (2009) Piya Lahiry et al. NATURE REVIEWS GENETICS
- Truncation of the Down Syndrome Candidate Gene DYRK1A in Two Unrelated Patients with Microcephaly
- (2008) Rikke S. Møller et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development
- (2008) Ariadna Laguna et al. DEVELOPMENTAL CELL
- DNA-damage repair; the good, the bad, and the ugly
- (2008) Razqallah Hakem EMBO JOURNAL
- DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine
- (2008) Anne Seifert et al. FEBS Journal
- Sprouty2-Mediated Inhibition of Fibroblast Growth Factor Signaling Is Modulated by the Protein Kinase DYRK1A
- (2008) S. Aranda et al. MOLECULAR AND CELLULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started